Virtus ETF Advisers’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-5,581
| Closed | -$113K | – | 416 |
|
|
2021
Q3 | $113K | Sell |
5,581
-299
| -5% | -$6.05K | 0.05% | 373 |
|
|
2021
Q2 | $219K | Sell |
5,880
-6,272
| -52% | -$234K | 0.09% | 280 |
|
|
2021
Q1 | $311K | Buy |
12,152
+213
| +2% | +$5.45K | 0.13% | 236 |
|
|
2020
Q4 | $263K | Sell |
11,939
-3,425
| -22% | -$75.4K | 0.11% | 293 |
|
|
2020
Q3 | $276K | Sell |
15,364
-2,097
| -12% | -$37.7K | 0.14% | 244 |
|
|
2020
Q2 | $444K | Buy |
17,461
+4,031
| +30% | +$103K | 0.21% | 166 |
|
|
2020
Q1 | $247K | Sell |
13,430
-1,941
| -13% | -$35.7K | 0.1% | 254 |
|
|
2019
Q4 | $339K | Sell |
15,371
-1,744
| -10% | -$38.5K | 0.06% | 286 |
|
|
2019
Q3 | $246K | Sell |
17,115
-953
| -5% | -$13.7K | 0.05% | 216 |
|
|
2019
Q2 | $285K | Buy |
+18,068
| New | +$285K | 0.06% | 238 |
|
|
2019
Q1 | – | Sell |
-24,457
| Closed | -$261K | – | 285 |
|
|
2018
Q4 | $261K | Buy |
+24,457
| New | +$261K | 0.04% | 155 |
|